Invivyd Promotes Marc Elia to CEO and Maps Dual Path for VYD2311 Data
Cantor keeps Overweight and a $10 target after the stock drop.
Already have an account? Sign in.
Cantor keeps Overweight and a $10 target after the stock drop.
Novartis and Ionis said pelacarsen lowered Lp(a) but failed to cut heart attacks, strokes or deaths in a Phase 3 trial of 8,323 patients.
Canaccord cites tinlarebant as the first drug shown to slow Stargardt lesion growth. The PDUFA date is February 12, 2027.
AMC CEO Adam Aron calls Robinhood’s AMC stock tokens vile and a fake market, demands a halt, and considers an SEC complaint.